These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11559240)

  • 1. Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma.
    McCune SL; Gockerman JP; Rizzieri DA
    JAMA; 2001 Sep; 286(10):1149-52. PubMed ID: 11559240
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
    Kaminski MS; Armitage JO
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-54-8. PubMed ID: 23570101
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody therapy for indolent lymphomas.
    Grossbard ML; Nadler LM
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):118-35. PubMed ID: 8211202
    [No Abstract]   [Full Text] [Related]  

  • 4. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
    Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
    Coiffier B
    Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibodies and immunoconjugates: new prospects in the treatment of non-Hodgkin's lymphomas].
    Sack A; Meusers P
    Strahlenther Onkol; 1999 Apr; 175(4):192-3. PubMed ID: 10230466
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-Hodgkin's lymphomas: understanding monoclonal antibody therapy.
    Hendrix C
    ONS News; 2006; 21(8 Suppl):19-20. PubMed ID: 16925135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of malignant low-grade lymphoma. Follicular Lymphoma Study Group].
    Solal-Celigny P
    Rev Med Interne; 1998; 19 Suppl 1():18S-20S. PubMed ID: 9789523
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.
    Long J; Versea L
    Semin Oncol Nurs; 2006 May; 22(2):97-106. PubMed ID: 16720232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
    Maloney DG; Press OW
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic agents in the management of Hodgkin lymphoma.
    Rashidi A; Bartlett NL
    J Natl Compr Canc Netw; 2015 May; 13(5):587-96. PubMed ID: 25964642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of monoclonal antibody immunoconjugates in cancer therapy.
    Pietersz GA; Krauer K; McKenzie IF
    Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monoclonal antibodies in therapy of malignant lymphomas].
    Buske C; Engert A; Schnell R; Diehl V; Hiddemann W
    Internist (Berl); 1998 Dec; 39(12):1205-14. PubMed ID: 10198827
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.
    Kawashima H
    ScientificWorldJournal; 2014; 2014():492061. PubMed ID: 25379535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody therapy with autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Aksentijevich I; Flinn IW
    Cancer Control; 2002; 9(2):99-105. PubMed ID: 12008655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
    Witzig TE; Gordon LI; Cabanillas F; Czuczman MS; Emmanouilides C; Joyce R; Pohlman BL; Bartlett NL; Wiseman GA; Padre N; Grillo-López AJ; Multani P; White CA
    J Clin Oncol; 2002 May; 20(10):2453-63. PubMed ID: 12011122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunoconjugates: therapy of non-Hodgkin lymphomas and colorectal carcinomas].
    Griesinger F; Trümper L; Becker W
    Internist (Berl); 2001 Jun; 42(6):860-4, 866-73. PubMed ID: 11449633
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.
    Press OW
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S19-26. PubMed ID: 9672771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody treatment of solid tumors: a coming of age.
    Murray JL
    Semin Oncol; 2000 Dec; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission.
    Buchegger F; Antonescu C; Helg C; Kosinski M; Prior JO; Delaloye AB; Press OW; Ketterer N
    J Nucl Med; 2011 Jun; 52(6):896-900. PubMed ID: 21571800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.